Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro
Clinical trial NCT04254380 · WITHDRAWN
Trial details
- NCT number
- NCT04254380
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2020-01-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.